Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -8,770 | -11,060 | -3,870 | 20 |
| Depreciation Amortization | 1,510 | N/A | N/A | N/A |
| Other Working Capital | 1,780 | N/A | N/A | N/A |
| Other Operating Activity | 730 | 3,430 | 1,240 | 740 |
| Operating Cash Flow | $-4,750 | $-7,630 | $-2,630 | $760 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -12,500 | N/A | N/A | N/A |
| Other Investing Activity | 580 | -35,650 | -50,180 | -10,090 |
| Investing Cash Flow | $-11,920 | $-35,650 | $-50,180 | $-10,090 |
| Cash Flows From Financing Activities | ||||
| Dividend Paid | -600 | N/A | N/A | N/A |
| Other Financing Activity | 17,320 | 45,960 | 46,040 | 10,390 |
| Financing Cash Flow | $16,720 | $45,960 | $46,040 | $10,390 |
| Beginning Cash Position | 4,480 | 1,800 | 8,650 | 7,580 |
| End Cash Position | 4,530 | 4,480 | 1,860 | 8,650 |
| Net Cash Flow | $50 | $2,670 | $-6,780 | $1,060 |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,750 | -7,630 | -2,630 | 760 |
| Free Cash Flow | -4,750 | -7,630 | -2,630 | 760 |